|
3 Reasons to Buy Gilead Sciences, Inc.
Motley Fool Last December, Gilead announced that a late-stage trial for idelalisib was stopped early because patients receiving a combo of idelalisib plus rituximab showed a highly significant improvement in overall survival and progression-free survival. With the … Standard Review for Gilead’s Oncology Candidate – Analyst BlogNASDAQ Gilead’s Idelalisib NDA accepted by US FDA for the treatment of refractory …MENAFN.COM |
Delhi health minister Satyendra Jain vows to donate his organs – Times of India
|
Delhi health minister Satyendra Jain vows to donate his organs
Times of India What can be a greater service to humanity than saving such lives by donating one’s organs post-death?” said Jain. He said that more people should come forward to pledge their organs. Director of ILBS S K Sarin urged people to donate organs saying … |
Undertrial shot in Noida court – Times of India
|
Undertrial shot in Noida court
Times of India Prima facie it appears that his liver was severely damaged. We took him to the ICU where he died while he was being stabilized,” Kapoor said. SSP Preetinder Singh said a total of 35 cases were lodged against the deceased. “We are waiting for the … |
Princess Cruises Raising $1 Million for the American Heart Association – Cruise Fever
Cruise Fever |
Princess Cruises Raising $1 Million for the American Heart Association
Cruise Fever Dr. Kathy Magilato, MD, MBA, FACS is one of the few female cardiothoracic surgeons specializing in heart transplantation, heart failure, and mechanical/artificial heart technology. She is the director of the Women’s Cardiac Services at Saint John’s … |
Chemical pollution linked to infection, bladder cancer – Times of India
Chemical pollution linked to infection, bladder cancerTimes of IndiaGastrointestinal infections, typhoid, anemia, kidney and liver damage are some of the common health problems associated with chemical pollutants. Doctors say high levels of amine, a de…
Robot-assisted surgery may preserve kidney function – Manoramaonline
|
Robot-assisted surgery may preserve kidney function
Manoramaonline In a ground-breaking study, researchers at Henry Ford Hospital’s Vattikuti Urology Institute in Detroit, Michigan, found that patients who received robot-assisted partial nephrectomy to treat kidney cancer had minimal loss of kidney function – a … |
Kalam Wants Strengthening of Healthcare System – Outlook
|
Kalam Wants Strengthening of Healthcare System
Outlook That means a new liver they can create and if it happens we may enter a new world and India may be the pioneer.” Director of ILBS S K Sarin urged people to donate organs saying, “Organ donation and pledging is worthwhile at any age.” He narrated the … |
Standard Review for Gileads Oncology Candidate – Zacks.com
|
Standard Review for Gileads Oncology Candidate
Zacks.com The patients were refractory to both Roche’s (RHHBY) Rituxan (rituximab) and to chemotherapy inclusive alkylating-agent. A decision from the FDA is expected by Sep 11, 2014. Apart from iNHL, idelalisib is also being evaluated in other oncology … Gilead’s Idelalisib NDA accepted by US FDA for the treatment of refractory …MENAFN.COM |
More teens lack HSV-1 antibodies – ModernMedicine
More teens lack HSV-1 antibodiesModernMedicineAn increasing number of American adolescents lack herpes simplex virus (HSV) type 1 antibodies, making them more susceptible to genital herpes following sexual debut, according to a recent study in The Jour…
Agenus Inc. – "Are We Getting Closer to Curing Cancer With Checkpoint … – MarketWatch
|
Agenus Inc. – “Are We Getting Closer to Curing Cancer With Checkpoint …
MarketWatch Read the full blog post on TheChairmansBlog.com ( http://www.thechairmansblog.com/agenus/garo-armen/getting-closer-curing-cancer-checkpoint-antibodies/ ). About Agenus. Agenus Inc. is a biotechnology company working to develop treatments for … |